| Literature DB >> 35290154 |
Xiaohui Zou1,2,3, Lijun Suo4,5, Yiming Wang1,2,3, Hongyun Cao5,6, Shengrui Mu1,2,3, Chao Wu7, Lizhen Yan4,5, Xiaowei Qi4,5, Jianwei Lu4,5, Binghuai Lu1,2,3, Yanyan Fan1,2,3, Hui Li1,2,3, Lixue Huang1,2,3, Lili Ren7,8, Bo Liu4,5,6, Bin Cao1,2,3,9,10.
Abstract
Pigeon paramyxovirus type 1 (PPMV-1), an antigenic variant of avian paramyxovirus type 1 (APMV-1), mainly infects pigeons. PPMV-1 genotype VI is the dominant genotype infecting pigeons in China. Human infection of avian paramyxovirus was rarely reported, and usually developed mild symptoms, such as conjunctivitis. We detected PPMV-1 in the lower respiratory sample from a fatal case with severe pneumonia; this patient aged 64 years presented cough, fever, and haemoptysis for 8 days and was admitted to hospital on Dec 26, 2020. He developed acute respiratory distress syndrome and sepsis in the following days and died of multiple organ failure on Jan 7, 2021. Sputum and blood culture reported multidrug-resistant Acinetobacter baumannii (ABA) for samples collected on days 22 and 19 post-illness, respectively. However, clinical metagenomic sequencing further reported PPMV-1 besides ABA in the bronchoalveolar lavage fluid. The PPMV-1 genome showed 99.21% identity with a Chinese strain and belonged to VI genotype by BLAST analysis. Multiple basic amino acids were observed at the cleavage site of F protein (113RKKRF117), which indicated high virulence of this PPMV-1 strain to poultry. The patient had close contact with pigeons before his illness, and PPMV-1 nucleic acid was detected from the pigeon feather. PPMV antibody was also detected in the patient serum 20 days after illness. In conclusion, concurrent PPMV-1 genotype VI.2.1.1.2.2 and ABA infection were identified in a fatal pneumonia case, and cross-species transmission of PPMV-1 may occur between infected pigeons and the human being.Entities:
Keywords: Newcastle diseases virus; clinical metagenomics; cross-species transmission; pigeon paramyxovirus type 1; pneumonia
Mesh:
Year: 2022 PMID: 35290154 PMCID: PMC8973364 DOI: 10.1080/22221751.2022.2054366
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163
Figure 1.Timeline of the clinical course of the patient and identification of the causative pathogen.
Figure 2.Chest radiographs during the clinical course. Bilateral ground-glass opacity and consolidation were observed on day 9 (Dec 26, Panel A) and worsened on day 11 (Dec 28, Panel B). Bilateral lung involvement was slightly relieved on day 14 (Dec 31, Panel C) after methylprednisolone was administrated on day 11. Bilateral ground-glass opacity and consolidation continued till day 16 (Jan 2, Panel D) and day 18 (Jan 4, Panel E) and relieved slightly on day 20 (Jan 6, Panel F).
Clinical blood biochemistry tests and gas analysis.
| Normal range | Days after illness onset | ||||||
|---|---|---|---|---|---|---|---|
| 3 | 9 | 11 | 14 | 17 | 20 | ||
| Number of white blood cells (×109 /L) | 3.5-9.5 | 7.04 | 8.43 | 11.57 | 10.17 | 10.29 | |
| Proportion of neutrophils (%) | 40–75 | 94.5 | 95.5 | 96 | 94 | 96.7 | |
| Proportion of lymphocytes (%) | 20–50 | 3.7 | 3.2 | 2.5 | 3.8 | 1.7 | |
| Neutrophils count (×109 /L) | 1.8–6.3 | 6.26 | 7.97 | 11.05 | 9.06 | 9.56 | 9.95 |
| Lymphocytes (×109 /L) | 1.1–3.2 | 0.44 | 0.31 | 0.37 | 0.24 | 0.39 | 0.18 |
| C-reactive protein (nmol/L) | 0–10 | 164.52 | 148.78 | 144.88 | |||
| Alanine aminotransferase(U/L) | 9–50 | 37 | 30 | 29.8 | 45.8 | 39.6 | 42.6 |
| Aspartate aminotransferase (U/L) | 15–40 | 34 | 36 | 58.4 | 67.2 | 57 | 56.4 |
| Alkaline phosphatase (U/L) | 45–125 | 95 | 202.2 | 172.8 | 192 | ||
| Total protein (g/L) | 65–85 | 49 | 44.2 | 49.7 | 47.5 | 50.5 | |
| Globin (g/L) | 20–40 | 21.5 | 22.9 | 22.4 | 23.4 | ||
| Albumin (g/L) | 40–55 | 32.5 | 24.7 | 22.7 | 26.8 | 25.1 | 27.1 |
| D-dimer (mg/L) | 0–0.55 | 4.7 | > 20 | 14.8 | |||
| Uric Acid (μmol/L) | 149–446 | 131 | 117 | 282 | |||
| Creatinine (μmol/L) | 44–105 | 80 | 62.5 | 59.44 | 62.5 | 123.7 | |
| Procalcitonin (ng/ml) | 0–0.5 | 0.335 | 1.511 | 1.218 | 1.24 | 46.754 | |
| FiO2% | 21–100 | 40 | 85 | 45 | 60 | 75 | |
| PaCO2 (mmHg) | 35–45 | 35 | 59 | 51 | 43 | 108 | |
| PaO2 (mmHg) | 80–100 | 67 | 55 | 63 | 57 | 58 | |
| PaO2/FiO2 (mmHg) | 400–500 | 167.5 | 64.7 | 140 | 140 | 77.3 | |
| pH | 7.35–7.45 | 7.46 | 7.29 | 7.3 | 7.47 | 7.16 | |
Abbreviations: FiO2%: fraction of inspired oxygen; PaCO2: partial pressure of carbon dioxide; PaO2: arterial partial pressure of oxygen.
Complications, treatment, and clinical outcome of the patients.
| Signs and treatment | |
|---|---|
| Fever | Yes |
| Temperature on admission (°C) | 36.4 |
| Highest temperature (°C) | 39.8 |
| Complications | |
| Failure of respiratory function | Yes |
| Septic shock | Yes |
| Heart failure | Yes |
| Liver failure | Yes |
| Oxygen treatment | Yes |
| Bacterial co-infection | Yes ( |
| Antibiotic treatment | Yes |
| Days 1–8 | Moxifloxacin, ganciclovir, and then switched to cefperazone-Sulbactam and levofloxacin (does unknown) |
| Days 9–19 | Imipenem (1 g given intravenously every 8 h) |
| Moxifloxacin (one 0.4 g dose given intravenously) | |
| Days 19–20 | Vancomycin (0.5 g given intravenously every 12 h) |
| Piperacillin/Tazobactam (4.5 g given intravenously every 8 h) | |
| Day 21 | Meropenem (1 g given intravenously every 12 h) |
| Glucocorticoid treatment | |
| Days 11–20 | Methylprednisolone (40 mg given intravenously every 12 h) |
| Antiviral treatment | |
| Days 10–18 | Ganciclovi (0.35 g given intravenously every 12 h) |
| Days 11–18 | Oseltamivir (75 mg given orally twice a day) |
| Days 18–21 | Arbidol (three 0.2 g doses given orally) |
| Antifungal treatment | |
| Days 19–20 | Micafungin Sodium (one 100 mg dose given intravenously) |
| Intravenous albumin therapy | 10 g (day 9-11) |
Figure 3.Metagenomic analysis of the clean reads after host sequences were removed. (A) The complete genome of reference APMV-1 strain pigeon/China/SDLC/2011 was fully covered by 3,289 reads with a mean depth of 31.2×. (B) taxa assignment of the clean reads using MEGAN software. Taxa and the number of their assigned reads were labelled in the polygenetic tree. The pie chart showed Acinetobacter baumannii contributed the most reads, followed by pigeon APMV-1 virus, among the reads of microorganism origin.
Figure 4.Phylogenetic classification of the APMV-1 virus using the full-length nucleotide sequence of the fusion gene, according to the phylogenetic classification system suggested by Dimitrov et al. [21]. The patient’s APMV-1 virus clustered with pigeon strains isolated in north China and belonged to genotype VI.2.1. Pigeon strains from China were labelled with a green triangle and the patient’s APMV-1 strain was labelled with a red circle. The cleavage sites of the fusion protein were aligned for several strains shown in the bottom-right corner, from which multiple basic amino acids were observed, indicating high virulence of the patient’s strain to poultry. Strain name abbreviations: Human/NY, Avian paramyxovirus 1 from the lethal human case of pneumonia reported by Goebel, et al. [15]; Human/SD, APMV-1 strain from our case occurred in Shangdong province in China; pigeon/1344, pigeon/Qinghai/1344/2017; pigeon/TJ2017, pigeon/China/TJ201; Pigeon/190610, Pigeon/Shandong/190610-2/2019; Pigeon/3P3, Pigeon/Shandong/3P3/2018.